In 2021 Walmart announced a new low-priced insulin for patients with diabetes. Is this good news? Yes, for some patients. Walmart already offers an older formulation of human insulin, ReliOn Novolin, for $25 per vial. Adding a low-cost rapid-acting analog insulin -- ReliOn Novolog -- to the Walmart ReliOn brand should help patients who are better treated with this modern analog insulin and who would otherwise be paying the full list price. Yet, this lower cost option is not enough to fully address the issue of insulin affordability and it highlights the systemic problems we face in the U.S. regarding the high costs of needed prescription drugs. This is still too high a price for a needed drug. While Walmart's ReliOn Novolog is priced at a significant savings off the list price -- $73 per 10 mL vial compared to $289 for branded NovoLog -- this price is still high compared to the rest of the world. It is many times higher than the $6 to $13 per vialopens in a new tab or window consumers pay for rapid-acting analog insulin in OECD (Organisation for Economic Co-operation and Development) countries outside the U.S. It is also significantly higher than the $6 to $7 per 10 mL vialopens in a new tab or window studies have estimated it costs to manufacture this type of insulin and bring it to market. A typical patient using two vials of rapid-acting insulin per month will spend $1,749 per year for Walmart's ReliOn Novolog. While much less than the $6,945 full list price, this is still a very high price for an essential drug.
没有医疗保险怎么办。还不知道怎么买保险。像这种慢性病一般保险不包括吧。
国内医生的处方也可以在美国买药吗？主要是胰岛素一次带不了很多。
就是一次带不了很多。不知道能不能邮寄。
这个信息很重要。请问一下具体是什么样的吗？谢谢！
Is this good news?
Yes, for some patients. Walmart already offers an older formulation of human insulin, ReliOn Novolin, for $25 per vial. Adding a low-cost rapid-acting analog insulin -- ReliOn Novolog -- to the Walmart ReliOn brand should help patients who are better treated with this modern analog insulin and who would otherwise be paying the full list price.
Yet, this lower cost option is not enough to fully address the issue of insulin affordability and it highlights the systemic problems we face in the U.S. regarding the high costs of needed prescription drugs.
This is still too high a price for a needed drug. While Walmart's ReliOn Novolog is priced at a significant savings off the list price -- $73 per 10 mL vial compared to $289 for branded NovoLog -- this price is still high compared to the rest of the world. It is many times higher than the $6 to $13 per vialopens in a new tab or window consumers pay for rapid-acting analog insulin in OECD (Organisation for Economic Co-operation and Development) countries outside the U.S. It is also significantly higher than the $6 to $7 per 10 mL vialopens in a new tab or window studies have estimated it costs to manufacture this type of insulin and bring it to market. A typical patient using two vials of rapid-acting insulin per month will spend $1,749 per year for Walmart's ReliOn Novolog. While much less than the $6,945 full list price, this is still a very high price for an essential drug.
楼上的贴了， 便宜的是25，贵的是70多，笔是80多。 2017年还没有Walmart笔，只有25的瓶子，打了以后血糖控制的也挺好，就是麻烦，每次抽出来几个单位。
同样产品在不同地方的价格差别好大哦……
前阵在tiktok上听加州州长吹牛逼，说他的政绩是让加州本地生产胰岛素，一劳永逸在加州解决这个价格问题
现在请教加州的ID们，他这政绩落地实现了嘛？还是吹个牛逼而已
如果实现了，还是可以的
Mark 谢谢